drugset / Trial / NCT06650540

Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis

NCT06650540

Not yet recruiting 800 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a single randomised controlled trial. The investigators plan to randomise 800 participants to the levofloxacin plus metronidazole suppositories versus levofloxacin co-administered with metronidazole tablets for the treatment of chronic endometritis in a 1:1 rate. Primary outcome will be the live birth rate after the embryo transfer.

Timeline

Start
2024-10-22
Primary completion
2025-10-22
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule Oral
Subject Metronidazole Small molecule Oral

Indications

No indication recorded.